An interventional study of Mirror priming and Conventional therapy in Cardiovascular Diseases, Stroke and Cerebrovascular Disorders, sponsored by I-Shou University. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-25.
Sponsored by I-Shou University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 394 studies in Stroke with a site in Taiwan — 73 open to participants now, 82 under way, 4 of them phase 3. Stroke · Taiwan.
Among the 394 studies in Stroke with a site in Taiwan, this one is the 112th largest by planned enrollment of the 337 interventional ones that give a count, is one of 9 that started in 2026, is one of 261 with no phase, reaches primary completion later than 80 of the 81 other live ones, and was the 375th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →73 of the 394 studies in Stroke with a site in Taiwan are open now. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–80
National Cheng-Kung University Hospital · Sites in Taiwan
Ages 20–80 · Healthy volunteers
Chimei Medical Center · Sites in Taiwan
Ages 65–90
Eli Lilly and Company · Sites in Taiwan, Argentina, Australia and 35 more countries
Ages 50+
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20+ · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 20 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
394 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 17 · Phase 2 26 · Phase 3 37 · Phase 4 5
First in 1998; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 81 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 54 across the 337 interventional studies, 100 across the 56 observational. Of the 207 that completed or were terminated, 15 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
36 of 394 have an industry lead sponsor. The 10 most frequent:
I-Shou University is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
I-Shou University has 2 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
20 of the studies in Stroke with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06204744Chang Gung Memorial HospitalHome-based Arm and Hand Exercise Program for Stroke: A Multisite Trial | 2026-12 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT04874454National Taiwan University HospitalEvaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke | 2026-12-31 |
| NCT07620210Chimei Medical CenterEffects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults | 2026-12-31 |
| NCT06883357National Taiwan University HospitalThe Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke. | 2026-12-31 |
Add all 20 to your calendar (.ics) → With an account.
Among the 394 studies in Stroke with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial aims to examine the effects of enhanced mirror priming, overcoming the limitations of traditional mirror therapy, to achieve optimization and personalized intervention.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
This study's planned enrollment of 81 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Browse Stroke studies →I-Shou University is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
Compared within Stroke, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Cardiovascular Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Mirror priming · Behavioral: Conventional therapy
Behavioral: Mirror priming · Behavioral: Conventional therapy
Behavioral: Conventional therapy
During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback.
Conventional therapy is individualized and may include impairment-oriented, shaping, or whole-task practice.
Fugl-Meyer Assessment
Time frame: Baseline, 2 weeks, 4 weeks, and 3 months post-intervention.
Grip and pinch power
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Revised Nottingham Sensory Assessment
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Berg Balance Scale
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Motor Activity Log
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
ABILHAND Questionnaire
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Chedoke Arm and Hand Activity Inventory
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Stroke Impact Scale
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Stroke Self-Efficacy Questionnaire
Time frame: Baseline, 4 weeks, and 3 months post-intervention.
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Sep 2030, 55 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 55 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
I-Shou University